MDL TrackerAntitrust

Google Digital Advertising

MDL No. 3010  ·  U.S. District Court for the Southern District of New York
MDL No.
3010
Docket Type
Antitrust
Transferee Judge
Hon. P. Kevin Castel
Centralized
2021-08-10
Actions Pending
32
As Of
2026-09-01
Funding Considerations

The Google Digital Advertising MDL, consolidated in the Southern District of New York since August 2021 under Judge P. Kevin Castel, brings together publisher- and advertiser-side claims that Google's ad exchange and ad server practices suppressed competition and inflated the effective cost of buying and selling digital ad inventory. For a funder assessing this docket, the plaintiff population is almost entirely commercial: news publishers, digital media companies, and advertisers rather than individual consumers, which means claim files center on revenue and spend records rather than personal documentation, and underwriting turns on the strength of a claimant's transaction history with the relevant ad exchanges.

This is a docket where funding availability should track the sophistication of the underlying economic proof. Ad-tech antitrust claims typically require detailed reconstruction of auction mechanics and take-rate data to show harm, which means early-stage claims carry more modeling uncertainty than claims filed by parties with detailed platform-level transaction records already in hand. A funder pricing a claim here will weight how well-documented a publisher's or advertiser's ad-spend and revenue history is, not just the size of the alleged harm.

For a firm building inventory around publisher- or advertiser-side ad-tech claims, portfolio finance is a natural structure: claims share a common defendant and a common theory of harm even where individual claimants differ substantially in transaction volume, and a book-level facility can smooth that variance better than one-off funding. This docket also runs alongside significant government antitrust enforcement targeting overlapping ad-tech conduct, which is a meaningful timing variable for any funding structure — developments in parallel government proceedings can affect timing and available evidence even though they don't determine the private plaintiffs' recovery directly.

There is no medical-lien dimension here; this is commercial claim funding against advertising-revenue harm, best evaluated under Criterica Capital's commercial litigation finance framework given the size and specialization of the underlying economic proof. A structural brief on the litigation itself, separate from the funding analysis, is available through Criterica Intelligence for firms weighing timing against portfolio commitments.

Frequently Asked Questions
Who are the plaintiffs in the Google Digital Advertising MDL, and can they get funding now?
+
How does the parallel government antitrust case against Google affect funding timing?
+
Is portfolio finance available for a firm representing multiple publishers or advertisers in this MDL?
+
What records matter most when a funder evaluates a claim in this docket?
+

Pre-settlement funding is a non-recourse purchase of a portion of the proceeds of a pending legal claim — not a loan. If the case does not result in a recovery, nothing is owed. Rates, fees, and repayment terms are disclosed in full in the funding agreement, which the applicant’s attorney reviews before signing. Availability and terms vary by state.

Litigation structure and resolution-risk brief on Criterica Intelligence →
Holding Google Digital Advertising claims or inventory?
Send the details and our institutional team will respond within one business day.